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requiring a higher radiotherapy dose. A second consideration 
is the characteristic of the vertebral metastasis and divides 
the metastases into uncomplicated or complicated. A 
systematic review suggested the following working definition 
for uncomplicated bone metastases: those unassociated with 
impending or existing pathologic fracture or existing spinal 
cord compression or cauda equina compression. Although this 
definition looks straightforward it is still variable to 
interpretation and might be incomplete. The Spinal 
Instability Neoplastic Score (SINS) might help us estimate the 
risk of vertebral fracture limiting SBRT to stable and 
potentially unstable metastases. Different definitions of 
spinal cord compression are available with the minimum 
evidence for cord compression being indentation of the 
thecal sac at the level of clinical features. Finally, other 
aspects such as, primary tumour type, other metastases, 
symptoms, practical considerations, current systemic 
treatment and previous radiotherapy… should be taken into  
TECHNICAL CONSIDERATIONS  
For treatment simulation several options are available for 
patient immobilization. Independent of the system used, the 
patient must be positioned in a stable position capable for 
reproducibility of positioning, allowing the patient to feel as 
comfortable as possible. A typical CT scan length should 
extend at least 10 cm superior and inferior beyond the 
treatment field borders (slice thickness of ≤2.5 - 3 mm). CT 
contrast will help visualize the soft tissue and adjacent 
normal tissues. The International Spine Radiosurgery 
consortium developed a consensus guideline for target 
volume definition. MRI images are mandatory for delineation. 
Axial volumetric T1 and T2 sequences without gadolinium are 
a standard with ≤3 mm slice thickness. Contouring of norm al 
tissue should be standardized for example: start contouring 
at 10 cm above the target volume to 10 cm below the target 
(RTOG 0631). Different fractionation schedules exist with 
variable total doses. None of the proposed schedules is 
proven to be superior to another. In case of single fraction, 
the doses vary between 16 and 24 Gy, with a strong trend for 
increasing pain relief with higher radiation doses, particularly 
with doses ≥ 16 Gy. In case of fractionated radiotherapy, 
doses vary between 7-10 Gy for a 3 fraction schedule and 
between 5-6 Gy for a 5 fraction schedule. Most centers 
prescribe the dose (Dpr) to a % volume of the PTV. A PTV 
dose coverage of <80% of the Dpr should be avoided (RTOG 
0631). This Dpr. should be prescribed to the isocenter or 
periphery of target. To minimize the risk for toxicity it is 
advised to strictly adhere to the published dose-constraints 
keeping in mind that they are mostly unvalidated. Control 
and correction of the patient and tumor position should be 
done with volumetric or stereoscopic X-ray imaging at least 
before each treatment fraction. Extensive recommendations 
and guidelines for a stereotactic or high precision QA 
program, supplementing the QA program for linear 
accelerators can be found in literature and should be 
followed (e.g. AAPM TG 101 report).  
OUTCOME  
The International Bone Metastases Consensus Working Party 
developed guidelines for the assessment of endpoints of 
palliative radiotherapy of bone metastases. It is 
recommended to follow the proposed definitions of pain 
assessment and pain response. Toxicity should evaluated at 
follow up visits using standardized criteria such as the 
National Cancer Institute (NCI) Common Terminology Criteria 
for Adverse Events (CTCAE) v.4.0. 
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Intensity-modulated radiotherapy (IMRT) has been introduced 
in a number of disease in the late nineties for treating 
complex treatment volumes and avoiding close proximity 
organs at risk (OAR) that may be dose limiting. Fifteen years 
later, in many countries, IMRT is still not considered as a 
standard technique for treating gynaecological cancers. It is 
well accepted that, if reducing acute and chronic toxicity are 
the main endpoints, IMRT may be considered as the ideal 
technique. By contrast, if disease-related outcomes are 
considered, there are still insufficient data to recommend 
IMRT over three-dimensional conformal radiotherapy. 
Moreover, with the increased accuracy of treatment delivery 
comes the need for greater accuracy in incorporation of 
organ motion to prevent geographical misses. 
Uterus significantly moves according to the bladder and 
rectal filling. The majority of motion occurs in the anterior–
posterior and superior–inferior directions, with mean 
interfraction movements of 4–7 mm, but very large 
displacements up to more than 2 cm may occur with the 
inherent risk of poor coverage of the posterior part of the 
cervix or of the uterine fundus. Similarly, during post-
operative irradiation, the vaginal CTV changes its position 
with standard deviation of 2.3 cm into the anterior or 
posterior direction, 1.8 cm to left or right and 1.5 cm 
towards the cranial. According to the majority of studies a 
uniform CTV planning treatment volume margin of 15 mm 
would fail to encompass the CTV in 5% of fractions in post-op. 
It rises up to 32%, when the CTV includes the entire uterus. 
For intact cervical cancer, where gross disease is present, the 
significant shrinkage in tumour volume of 62% in mean, also 
contributes to potential unintended doses to normal tissues, 
but the risk is rather low.  
How to deal with motion uncertainties? 
It can be helpful to attempt to control rectum and bladder 
filling, although the compliance with instructions for bladder 
filling and for rectal emptying does not always result in 
adequate reproducibility. The construction of an ITV from CT 
images acquired with empty and full bladder is also another 
way to account for interfraction motion of the CTV. The 
implementation of IGRT on a daily basis is essential for 
judging the effectiveness of the measures previously 
outlined. However, one must never forget that the cervix or 
vaginal cuff and surrounding tissues are mobile relative to 
the bony pelvis, while the pelvic lymph nodes which are also 
part of the target are relatively fixed. Thus, the shifts to 
account for motion of the mobile target may move the pelvic 
lymph nodes out of the PTV. Consequently, care should be 
taken when shifting to ensure that nodal targets are still 
within PTV, but keeping CTV to PTV margins to 10-15 mm 
helps to find a good compromise without jeopardizing the 
OAR’s sparing. The risk of geographical misses does exist, but 
its level must be appreciated in the light of the dose 
contribution brought by the additional brachytherapy. 
Brachytherapy still plays a major role in the treatment of 
cervix carcinomas. The important dose gradient and the 
absence of target movements in relation to the inserted 
radioactive sources allow for dose escalation and 3D image 
guided adaptative procedure allows for accurate definition of 
target volumes with definition of dose volume parameters. 
Consequently a moderate under dosage of a part of CTV 
during IMRT may be compensated by the high dose delivered 
by brachytherapy.  
The concept of adaptive IMRT seems to be applicable for the 
management of the complex deformable target motion that 
occurs during radiation of gynecological cancers. The cervix–
uterus shape and position can be predicted by bladder 
volume, using a patient-specific prediction model derived 
from pre-treatment variable bladder filling CTscans. Based on 
that, a strategy called “plan of the day” has been elaborated 
and is under investigation.  
In conclusion, organ motion is not an obstacle to the use of 
IMRT as standard technique for gynecological cancer, 
especially when combined with brachytherapy, provided that 
PTV margins are not reduced and IGRT is adequately used. 
The participation to prospective studies and/or the 
registration of patients in database are strongly encouraged.  
 
 
 
 
 
